[1] Stephen S Lim KA, Zulfiqar A Bhutta, Lalit Dandona, Mohammad H Forouzanfar, Nancy Fullman, Peter W Gething, Ellen M Goldberg. Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015. Lancet 2016,388:1813-1850.
[2] WHO. Global tuberculosis report. World Health Organization, Geneva;2018 https://www.who.int/tb/publications/global report/en/Date accessed:December 14, 2018
[3] Gninafon M, Tawo L, Kassa F, Monteiro GP, Zellweger JP, Shang H, et al. Outcome of tuberculosis retreatment in routine conditions in Cotonou, Benin. Int J Tuberc Lung Dis 2004,8:1242-1247.
[4] International Diabetes Federation. IDF Diabetes Atlas, seventh edition 2015.
[5] Boucot KR, Dillon ES, Cooper DA, Meier P, Richardson R. Tuberculosis among diabetics: the Philadelphia survey. Am Rev Tuberc 1952,65:1-50.
[6] Nichols GP. Diabetes among young tuberculous patients; a review of the association of the two diseases. Am Rev Tuberc 1957,76:1016-1030.
[7] Silwer H, Oscarsson PN. Incidence and coincidence of diabetes mellitus and pulmonary tuberculosis in a Swedish county. Acta Med Scand Suppl 1958,335:1-48.
[8] Alkabab YM, Enani MA, Indarkiri NY, Heysell SK. Performance of computed tomography versus chest radiography in patients with pulmonary tuberculosis with and without diabetes at a tertiary hospital in Riyadh, Saudi Arabia. Infect Drug Resist 2018,11:37-43.
[9] Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 2008,5:e152.
[10] Baker MA, Harries AD, Jeon CY, Hart JE, Kapur A, Lonnroth K, et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med 2011,9:81.
[11] Stop TB Department, World Health Organization, International Union Against Tuberculosis and Lung Disease. Collaborative framework for care and control of tuberculosis and diabetes. Geneva, Switzerland: WHO, The Union; 2011. WHO/HTM/TB/2011.15.
[12] Harries AD, Murray MB, Jeon CY, Ottmani SE, Lonnroth K, Barreto ML, et al. Defining the research agenda to reduce the joint burden of disease from diabetes mellitus and tuberculosis. Trop Med Int Health 2010,15:659-663.
[13] Dixon B. Diabetes and tuberculosis: an unhealthy partnership. Lancet Infect Dis 2007,7:444.
[14] Stevenson CR, Critchley JA, Forouhi NG, Roglic G, Williams BG, Dye C, et al. Diabetes and the risk of tuberculosis: a neglected threat to public health? Chronic Illn 2007,3:228-245.
[15] Faurholt-Jepsen D, Range N, Praygod G, Kidola J, Faurholt-Jepsen M, Aabye MG, et al. The role of diabetes co-morbidity for tuberculosis treatment outcomes: a prospective cohort study from Mwanza, Tanzania. BMC Infect Dis 2012,12:165.
[16] Faurholt-Jepsen D, Range N, PrayGod G, Jeremiah K, Faurholt-Jepsen M, Aabye MG, et al. Diabetes is a strong predictor of mortality during tuberculosis treatment: a prospective cohort study among tuberculosis patients from Mwanza, Tanzania. Trop Med Int Health 2013,18:822-829.
[17] Jimenez-Corona ME, Cruz-Hervert LP, Garcia-Garcia L, Ferreyra-Reyes L, Delgado-Sanchez G, Bobadilla-Del-Valle M, et al. Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes. Thorax 2013,68:214-220.
[18] Pizzol D, Di Gennaro F, Chhaganlal KD, Fabrizio C, Monno L, Putoto G, et al. Tuberculosis and diabetes: current state and future perspectives. Trop Med Int Health 2016,21:694-702.
[19] Pavlovic JM, Pavlovic AD, Bulajic MV, Pesut DP. Prevalence of diabetes mellitus (DM) in tuberculosis (TB) patients: clinical and radiologic features in the TB-DM association based on a five-year hospital study. Infez Med 2018,26:22-27.
[20] Pizzol D, Di Gennaro F, Chhaganlal KD, Fabrizio C, Monno L, Putoto G, et al. Prevalence of diabetes mellitus in newly diagnosed pulmonary tuberculosis in Beira, Mozambique. Afr Health Sci 2017,17:773-779.
[21] Haraldsdottir TL, Rudolf F, Bjerregaard-Andersen M, Joaquim LC, Stochholm K,Gomes VF, et al. Diabetes mellitus prevalence in tuberculosis patients and the background population in Guinea-Bissau: a disease burden study from the capital Bissau. Trans R Soc Trop Med Hyg 2015,109:400-407.
[22] Noubiap JJ, Nansseu JR, Nyaga UF, Nkeck JR, Endomba FT, Kaze AD, et al. Global prevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 2.3 million patients with tuberculosis. Lancet Global Health 2019,7:E448-E460.
[23] Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. Bmj 2009,339:b2700.
[24] Munn Z, Moola S, Riitano D, Lisy K. The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence. Int J Health Policy Manag 2014,3:123-128.
[25] World Bank Open Data. https://data.worldbank.org/
[26] Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994,50:1088-1101.
[27] Etminan N, Chang HS, Hackenberg K, de Rooij NK, Vergouwen MDI, Rinkel GJE, et al. Worldwide Incidence of Aneurysmal Subarachnoid Hemorrhage According to Region, Time Period, Blood Pressure, and Smoking Prevalence in the Population: A Systematic Review and Meta-analysis. JAMA Neurol 2019.
[28] StataCorp. 2015. Stata Statistical Software: Release 14. College Station, TX: StataCorp LP.
[29] Ponce-De-Leon A, Garcia-Garcia Md Mde L, Garcia-Sancho MC, Gomez-Perez FJ, Valdespino-Gomez JL, Olaiz-Fernandez G, et al. Tuberculosis and diabetes in southern Mexico. Diabetes Care 2004,27:1584-1590.
[30] Abdelbary BE, Garcia-Viveros M, Ramirez-Oropesa H, Rahbar MH, Restrepo Tuberculosis-diabetes epidemiology in the border and non-border regions of Tamaulipas, Mexico. Tuberculosis (Edinb) 2016,101s:S124-s134.
[31] Li XX, Wang LX, Zhang J, Liu YX, Zhang H, Jiang SW, et al. Exploration of ecological factors related to the spatial heterogeneity of tuberculosis prevalence in P. China. Glob Health Action 2014,7:23620.
[32] World Health Organization. Global tuberculosis report, 2012. WHO/HTM/ TB/2012.6. Geneva, Switzerland: WHO; 2012.
[33] Aftab H, Ambreen A, Jamil M, Garred P, Petersen JH, Nielsen SD, et al. High prevalence of diabetes and anthropometric heterogeneity among tuberculosis patients in Pakistan. Trop Med Int Health 2017,22:465-473.
[34] Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis 2009,9:737-746.
[35] Rathmann W, Giani G. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004,27:2568-2569; author reply 2569.
[36] Gil-Santana L, Almeida-Junior JL, Oliveira CA, Hickson LS, Daltro C, Castro S, et al. Diabetes Is Associated with Worse Clinical Presentation in Tuberculosis Patients from Brazil: A Retrospective Cohort Study. PLoS One 2016,11:e0146876.
[37] Imamura F, Micha R, Khatibzadeh S, Fahimi S, Shi P, Powles J, et al. Dietary quality among men and women in 187 countries in 1990 and 2010: a systematic assessment. Lancet Glob Health 2015,3:e132-142.
[38] Peer N, Kengne AP, Motala AA, Mbanya JC. Diabetes in the Africa Region: an update. Diabetes Res Clin Pract 2014,103:197-205.
[39] Adepoyibi T, Weigl B, Greb H, Neogi T, McGuire H. New screening technologies for type 2 diabetes mellitus appropriate for use in tuberculosis patients. Public Health Action 2013,3:S10-17.
[40] Harries AD, Kumar AM, Satyanarayana S, Lin Y, Zachariah R, Lonnroth K, et al. Diabetes mellitus and tuberculosis: programmatic management issues. Int J Tuberc Lung Dis 2015,19:879-886.
[41] Owiti P, Keter A, Harries AD, Pastakia S, Wambugu C, Kirui N, et al. Diabetes and pre-diabetes in tuberculosis patients in western Kenya using point-of-care glycated haemoglobin. Public Health Action 2017,7:147-154.
[42] Ronacher K, van Crevel R, Critchley JA, Bremer AA, Schlesinger LS, Kapur A, et al. Defining a Research Agenda to Address the Converging Epidemics of Tuberculosis and Diabetes: Part 2: Underlying Biologic Mechanisms. Chest 2017,152:174-180.
[43] Grint D, Alisjhabana B, Ugarte-Gil C, Riza AL, Walzl G, Pearson F, et al. Accuracy of diabetes screening methods used for people with tuberculosis, Indonesia, Peru, Romania, South Africa. Bull World Health Organ 2018,96:738-749.
[44] Mupere E, Malone L, Zalwango S, Okwera A, Nsereko M, Tisch DJ, et al. Wasting among Uganda men with pulmonary tuberculosis is associated with linear regain in lean tissue mass during and after treatment in contrast to women with wasting who regain fat tissue mass: prospective cohort study. BMC Infect Dis 2014,14:24.
[45] Rücker G, Schwarzer G, Carpenter JR, Schumacher M.Undue reliance on I(2) in assessing heterogeneity may mislead.BMC Med Res Methodol 2008; 8: 79.